MedTrace Logo

Investigation of Genetic Disease Marker Associated With Spontaneous Haemorrhagic Stroke Complicating Severe Pre-eclampsia in Pregnancy

NCT05121415 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2023-03-14

No results posted yet for this study

Summary

To search for a genetic marker of hemorrhagic stroke complicating severe eclampsia, a single nucleotide polymorphism (SNP) analysis of DNA obtained from the peripheral blood of patients with hemorrhagic stroke and normal control will be performed.

Conditions

  • Hemorrhagic Stroke
  • Eclampsia

Interventions

GENETIC

SNP analysis of the DNA

SNP analysis of the DNA obtained from peripheral blood sample

Sponsors & Collaborators

  • Asfendiyarov Kazakh National Medical University

    lead OTHER

Principal Investigators

  • Aygul Terlikbayeva, PhD · JSC "Scientific center of obstetrics, gynecology and perinatology"

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-23
Primary Completion
2023-01-20
Completion
2023-01-20

Countries

  • Kazakhstan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05121415 on ClinicalTrials.gov